Taipei, Taiwan

Shi-Yie Cheng

This inventor holds 1 USPTO granted patent. Top assignee: Aquavan Technology Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shi-Yie Cheng. Retrieved from https://idiyas.com/inventor/shi-yie-cheng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Shi-Yie Cheng

Introduction: Shi-Yie Cheng is a notable inventor based in Taipei, Taiwan. He has made significant strides in the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. His work exemplifies the intersection of innovation and healthcare, aiming to improve patient outcomes through scientific advancements.

Latest Patents: Shi-Yie Cheng holds a patent for "Substituted steroids for the treatment of cancer." This patent describes a compound and pharmaceutically acceptable salts that are effective in treating cancer. The structure of the compound is represented by specific formulas, showcasing the intricate design involved in his research.

Career Highlights: Cheng is currently associated with Aquavan Technology Co., Ltd., where he continues to contribute to the field of pharmaceutical innovation. His dedication to research and development has positioned him as a key figure in the fight against cancer.

Collaborations: Throughout his career, Shi-Yie Cheng has collaborated with talented individuals such as Yao-Ting Wang and Kuo-Tang Tseng. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion: Shi-Yie Cheng's work in developing cancer treatment compounds highlights the importance of innovation in healthcare. His contributions not only advance scientific knowledge but also hold the promise of improving lives through effective medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…